SCHEMBL13601448

SCHEMBL13601448

CCOC(=O)CCN1CCC(N2CCN(C(=O)[C@H](C)Cc3cc(C)c4[nH]c(=O)oc4c3)CC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 9/20 0.38
CYP3A4 P08684 4/20 0.38
CALCA P06881 3/20 0.35
ENPP2 Q13822 4/20 0.34
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
GAA P10253 1/20 0.33
ALOX12 P18054 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601492 0.97 CALCRL (0.39) CALCRLCYP3A4CALCAENPP2ALDH1A1
SCHEMBL13601335 0.92 CALCRL (0.37) CALCRLCYP3A4CALCAENPP2CHRM2
SCHEMBL13601494 0.92 CALCRL (0.38) CALCRLCYP3A4CALCAENPP2
SCHEMBL13601380 0.89 CALCRL (0.38) CALCRLCYP3A4CALCACHRM2CHRM4
SCHEMBL13601340 0.87 CALCRL (0.36) CALCRLCYP3A4CALCAENPP2
SCHEMBL13601401 0.86 CALCRL (0.32) CALCRLCYP3A4ENPP2ALDH1A1SMN1; SMN2
SCHEMBL13601530 0.85 KMT2A (0.44) CALCRLCYP3A4ALDH1A1CHRM2CHRM4
SCHEMBL13601342 0.85 CALCRL (0.35) CALCRLCYP3A4CALCAENPP2
SCHEMBL13601324 0.84 CALCRL (0.41) CALCRLCYP3A4CALCACHRM1
SCHEMBL13601343 0.84 CALCRL (0.35) CALCRLCYP3A4CALCAENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed